- SynonymsN-(6-amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamide; 6-Amino-5-formamido-1,3-dimethyl-uracil; 1,3-Dimethyl-4-amino-5-(formylamino)uracil; 6-Amino-1,3-dimethyl-5-(formylamino)pyrimidine-2,4-dione; N-(6-Amino-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)-formamid...
- Description
N-(6-amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamide; 6-Amino-5-formamido-1,3-dimethyl-uracil; 1,3-Dimethyl-4-amino-5-(formylamino)uracil; 6-Amino-1,3-dimethyl-5-(formylamino)pyrimidine-2,4-dione; N-(6-Amino-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)-formamide; N-(6-Amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamide; NSC 42307; Theophylline EP Impurity C; 6-Amino-5-1,3-dimethyl-5-(formamido)uracil
Caffeine EP Impurity B is a fully characterized chemical compound used as a reference standard of API Theophylline. The standard offered is compliant with regulatory guidelines. Caffeine EP Impurity B is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 7597-60-6